Barry Richard — SEC Form 4 filings
SEC reporting owner CIK 1562371. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-05 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 4 filings — 468,498 shares, $1,166,904 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: purchase of 185,233 shares @ $2.24 ($414,922) in CASSAVA SCIENCES INC, filed 2025-09-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CASSAVA SCIENCES INC (SAVA) | President & CEO, Director | 8 | 7 legs · 468,498 sh · $1,166,904 | — | 6 |
| Sarepta Therapeutics, Inc. (SRPT) | Director | 5 | — | — | 11 |
Form 4 filings — Barry Richard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 16,875 | EDGAR |
| 2025-11-24 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 150,000 @ $2.76 | EDGAR |
| 2025-11-20 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 73,385 @ $2.75 | EDGAR |
| 2025-09-23 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 7,172 @ $2.28 | EDGAR |
| 2025-09-22 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 5,400 @ $2.13 · Purchase (P): 185,233 @ $2.24 · Purchase (P): 400 @ $2.25 · Purchase (P): 46,908 @ $2.29 | EDGAR |
| 2025-05-19 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 12,350 @ $32.63 · Option exercise (M): 12,350 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 9,746 @ $25.18 · Option exercise (M): 10,500 @ $13.71 · Option exercise (M): 9,746 (derivative) @ $0 · Option exercise (M): 10,500 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | CASSAVA SCIENCES INC (SAVA) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 2,383 @ $0 · Grant/award (A): 4,792 (derivative) @ $0 | EDGAR |
| 2024-10-01 | 4 | CASSAVA SCIENCES INC (SAVA) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | CASSAVA SCIENCES INC (SAVA) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-04-25 | 4 | CASSAVA SCIENCES INC (SAVA) | Option exercise (M): 176,085 @ $22 · Grant/award (A): 117,390 (derivative) @ $0 · Option exercise (M): 117,390 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 1,846 @ $0 · Grant/award (A): 3,679 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1562371 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →